Paper published in The Lancet reflecting results of a trial into Central Serous Chorioretinopathy. Shared on Youtube too. Eplerenone has been used to treat patients but has side effects for some. After completion of the VICI study it is recommended that the drug is no longer prescribed for this condition as there are no benefits to be seen.
